SEC Form 4 · accession 0001179110-16-022593
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorothy Engelking
Officer — VP, Regulatory Affairs
Period of report
Apr 1, 2016
Accepted (ET)
Apr 1, 2016 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.74 | Apr 1, 2016 | A | 15,000 | A | — | Apr 1, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This stock option vests in four equal, annual installments, beginning on April 1, 2017.